ConductScience.org, home

Trial · NCT01479556

Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain

NCT01479556, Phase 4, Unknown, Julian Taylor Green

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain. Trials, record NCT01479556. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01479556

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain
NCT number
NCT01479556
Status
Unknown
Phases
Phase 4
Enrollment
82 participants, estimated
Lead sponsor
Julian Taylor Green
Conditions
Neuropathic Pain, Spinal Cord Injuries
Interventions
Pregabalin, Placebo
First posted
2011-11-24
Last updated
2011-11-24
Other registries' IDs
eudract:2011-000915-14

Source ClinicalTrials.gov

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDaily at-level non-evoked pain intensity measured with the numerical rating scale (0-10) expressed as the mean 7-day pain intensity
SecondaryWeekly below-level non-evoked pain intensity measured with the numerical rating scale (0-10)
SecondaryWeekly evaluation of at-level neuropathic pain symptoms using the "Neuropathic Pain Symptoms Inventory" (NPSI)
SecondaryWeekly evaluation of at-level neuropathic pain intensity and interference using the "Brief Pain Inventory" (BPI)
SecondaryWeekly evaluation of the change in at-level non-evoked neuropathic pain using the "Patient Global Impression Change" (PGIC)
SecondaryWeekly evaluation of anxiety and depression using the Hospital Anxiety and Depression Scale (HADS)
SecondaryWeekly evaluation of spasm frequency below the spinal cord injury using the Penn questionnaire
SecondaryMeasurement of the amplitude of cold and heat sensory evoked potentials (Cz-Fz) studied above (C4) and at-level of the SCI
SecondarySerum TNF-R1 level
SecondaryWeekly at-level non-evoked pain intensity measured with the numerical rating scale (0-10) 28 days after the termination of the clinical trial

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01479556

GET https://conductscience.org/api/trials/v1/NCT01479556/registered